DCGI approves vision-correcting eye drops

Imagine a world where we no longer need to reach for our

reading glasses

every time we pick up a book, check our phone, or at a menu. For millions of people over 40, this could soon be a reality. However,

Entod Pharmaceuticals

has introduced PresVu, India's first

eye drop

designed specifically to reduce dependence on reading glasses for those with

presbyopia

- a common age-related condition that makes it difficult to focus on close objects.

Here is all we need to know about what

PresVu

is and how it can benefit those who rely on reading glasses.

What are PresVu eye drops?

PresVu is a specially formulated eye drop developed by Entod Pharmaceuticals to target presbyopia - a condition that affects individuals over the age of 40. Presbyopia occurs when the eye's natural lens loses its flexibility, making it difficult to focus on close objects. This is a natural part of ageing and mostly leads to the use of reading glasses. PresVu aims to address this issue by improving the eye's focusing ability, thereby reducing the need for reading glasses.

How does PresVu work?

PresVu works by temporarily improving the flexibility of the eye’s lens, which deteriorates with age. When applied, the eye drop stimulates the muscles around the lens, helping it to change shape more easily and focus on nearby objects. This improvement in focusing ability allows people with presbyopia to see clearly at close range without the constant need for reading glasses. Entod Pharmaceuticals describes PresVu as a "solution that stands to improve the lives of millions by offering them greater visual independence," as stated by CEO Nikkhil K Masurkar.

Who can benefit from PresVu?

PresVu is designed for individuals who have been diagnosed with presbyopia and are looking for alternatives to reading glasses. According to industry estimates, between 1.09 to 1.8 billion people worldwide are affected by presbyopia, making this eye drop a potential solution for a large segment of the population. PresVu helps in reducing dependency on reading glasses which can provide a significant quality-of-life improvement for those who find glasses cumbersome or inconvenient.

Impact of eyecare in India

As the first eye drop in the country specifically developed for presbyopia, it opens new possibilities for treating this common condition. "This

DCGI approval

is a major step forward in our mission to transform

eye care

in India," noted Masurkar. The introduction of PresVu is expected to cater not only to the domestic market but also to emerging markets in Africa and Southeast Asia, where access to innovative eye care solutions is limited.
(With inputs from PTI)